Andrea van Elsas

Years Active: 2019-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Shuyu Huang, Sander M J van Duijnhoven, Alice J A M Sijts, Andrea van Elsas
Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy. Journal of cancer research and clinical oncology 146 (12) (2020)
Beth Hutchins, Gary C Starling, Mark A McCoy, Danuta Herzyk, Frederique M Poulet, John Dulos, Liming Liu, Soonmo Peter Kang, Laurence Fayadat-Dilman, Mark Hsieh, Christine L Andrews, Gulesi Ayanoglu, Constance Cullen, Rene de Waal Malefyt, Robert A Kastelein, Sabine Le Saux, Julie Lee, Sophie Li, Dan Malashock, Svetlana Sadekova, Gregory J Carven, Hans van Eenennaam, Aarron Willingham, Ying Yu, Michel Streuli, Andrea van Elsas
Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab. Molecular cancer therapeutics 19 (6) (2020)
Erik Voets, Marc Paradé, David Lutje Hulsik, Sanne Spijkers, Wout Janssen, Joost Rens, Inge Reinieren-Beeren, Gilbert van den Tillaart, Sander van Duijnhoven, Lilian Driessen, Maurice Habraken, Peter van Zandvoort, Joost Kreijtz, Paul Vink, Andrea van Elsas, Hans van Eenennaam
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint. Journal for immunotherapy of cancer 7 (1) (2019)

Andrea van Elsas.css-eqlu8i{font-size:small;padding-left:4px;}